FDA Inspection 1181313 — Sazerac North America, Inc.
The FDA completed an inspection of Sazerac North America, Inc. on Sep 19, 2022 in Owensboro, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 19, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Owensboro, KY (United States)